Re:Goldman Sachs questions whether curing patients is a sust...
by neuromantik8086 on Friday April 13, 2018 @12:57PM
(#16831766)
Intriguing. I've often speculated about how private sector research compared with public research, especially in the context of the reproducibility crisis since I assumed that a lot of pharma companies knew that some research couldn't be replicated behind closed doors. I wonder what the quality of proprietary / unreleased studies is- do the links you provide take that into account?
[ Parent
| on HN ]
Re:Goldman Sachs questions whether curing patients is a sust...
by cage433 on Friday April 13, 2018 @04:17PM
(#16833552)
It compares badly. Unfortunately too much private research is allowed to be kept secret - but what is known indicates it's of poorer quality - judged by the kind of metrics the Cochrane Institute use.
Goldacre's book (he also has a blog) is well worth reading - describing _many_ ways in which drug companies can cheat.